Schedule 13D ownership disclosure

CEREVEL THERAPEUTICS HLDNG I

Security class unavailable · CUSIP: 15678U128

Event date: 2022-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
27,349,211
Percent of class
18.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000078003-22-000051
Form type
SC 13D/A
Filer
Cerevel Therapeutics Holdings, Inc.
CIK
CIK 1805387
Filed
Apr 07, 2022
Reporting period
Mar 31, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub